Technology can be a vital partner in improving student engagement, keeping students on task and allowing educators to deliver ...

Arcturus Therapeutics shares plunged 56% after Phase 2 cystic fibrosis trial data showed no meaningful lung function ...

Marc Maron’s January 2010 set on John Oliver’s New York Stand-Up Show runs over 14 minutes, but that’s part of what makes it ...

Shares on Wednesday filed for regulatory approval to launch a passive exchange-traded fund that would track the price of Hype ...

Moradabad Police in Uttar Pradesh on Friday registered a first information report (FIR) against the principal, the admission ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Novartis will acquire Avidity Biosciences in a newly announced definitive merger agreement. The news follows the separation ...

The immune system has a tough job: When a tiny virus invades one of our cells, that cell must detect it and, within minutes, ...

Global listed infrastructure reasserted its value as a distinct allocation in 2025, delivering double-digit returns YTD. Read ...

Asian patients with non-cystic fibrosis bronchiectasis had a lower annualized exacerbation rate and less lung function ...

Roughly 60% of grades given to undergraduates were A’s, up from 40% a decade ago and less than a quarter 20 years ago, ...

A myasthenia gravis treatment revolution has taken place in the past four years, spurred by an initial approval for argenx’s ...